Genmab A/S (NASDAQ:GMAB) Q4 2025 Earnings Call Transcript February 17, 2026
Genmab A/S misses on earnings expectations. Reported EPS is $0.4035 EPS, expectations were $0.46.
Operator: Hello, and welcome to the Genmab Full Year 2025 Financial Results Conference Call. As a reminder, this conference call is being recorded. During this telephone conference, you may be presented with forward-looking statements that include words such as believes, anticipates, plans or expects. Actual results may...
